The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians against the consumption of recalled G-Fuel brand energy drinks which are sold by T&E Imports and GPAE Trading Corp over their high caffeine content.
The agency issued the warning through a public alert with No. 034/2023, issued to newsmen in Abuja.
The Director-General of NAFDAC, Prof. Mojisola Adeyeye, according to the statement, stated that the said energy drinks were found to contain high levels of caffeine which can cause several health problems such as headaches, insomnia, irritability, and nervousness, especially for people sensitive to caffeine.
Lafiya360 reports that the product was also recalled by the Netherlands Food and Consumer Product Safety Authority and the Canadian Food Inspection Agency.
Prof. Adeyeye stressed that headaches, insomnia, agitation, and anxiety could result from consuming products that contain high caffeine content, adding that those who are sensitive to caffeine might still suffer these negative effects from low doses.
The NAFDAC boss urged pregnant women to desist from consuming these products, stating that doing so with too much caffeine may have negative health implications such as increased risk of miscarriage and low birth weight kids.
She added that the recalled items which are sold online don’t have warning labels limiting the amount of servings per day.
She said, “The product is not registered by NAFDAC, which implored consumers and retailers to refrain from using, selling, serving, or distributing the implicated product.
“Members of the public are encouraged to report any suspicion of distribution and sale of unwholesome packaged food products to the nearest NAFDAC office.
“NAFDAC could also be reached on 0800-162-3322 or via email: alert@nafdac.gov.ng.
“Healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of any substandard NAFDAC-regulated product to the nearest NAFDAC office.
“NAFDAC could also be reached through the use of the E-reporting platforms available on the NAFDAC websitenafdac.gov.ng or via the Med-safety application available for download on Android and IOS stores.
“The public could also reach NAFDAC via e-mail: onpharmacovigilance@nafdac.gov.ng.”